(Q37798242)

23 August 2017

title

Progressive multifocal leukoencephalopathy and newer biological agents (English)

1 reference

progressive multifocal leukoencephalopathy

23 August 2017

main subject

0 references

author name string

Joseph R Berger

series ordinal

1

1 reference

23 August 2017

publication date

1 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

33

1 reference

23 August 2017

issue

11

1 reference

23 August 2017

page(s)

969-983

1 reference

https://scigraph.springernature.com/pub.10.2165/11537510-000000000-00000

23 August 2017

exact match

0 references

cites work

Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals.

1 reference

12 December 2020

Blockade of CD11a by Efalizumab in Psoriasis Patients Induces a Unique State of T-Cell Hyporesponsiveness

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

1 reference

12 December 2020

Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation

1 reference

12 December 2020

Incidence of infection during efalizumab therapy for psoriasis: analysis of the clinical trial experience

1 reference

12 December 2020

Identification and characterization of mefloquine efficacy against JC virus in vitro

1 reference

12 December 2020

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients

1 reference

12 December 2020

Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination

1 reference

12 December 2020

Asymptomatic reactivation of JC virus in patients treated with natalizumab

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

1 reference

12 December 2020

Effect of therapeutic integrin (CD11a) blockade with efalizumab on immune responses to model antigens in humans: results of a randomized, single blind study

1 reference

12 December 2020

Current concepts and review of efalizumab in the treatment of psoriasis

1 reference

12 December 2020

Seroepidemiology of the human polyomaviruses

1 reference

12 December 2020

Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus

1 reference

12 December 2020

The bone marrow, B cells, and JC virus

1 reference

12 December 2020

Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection

1 reference

12 December 2020

Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.

1 reference

12 December 2020

Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A.

1 reference

12 December 2020

Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases

1 reference

12 December 2020

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases

1 reference

12 December 2020

Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Seroepidemiology of human polyomaviruses

1 reference

12 December 2020

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis.

1 reference

12 December 2020

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Emerging monoclonal antibody therapies for multiple sclerosis

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in HIV-1-infected children

1 reference

12 December 2020

Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis

1 reference

12 December 2020

The status of biologic therapies in the treatment of moderate to severe psoriasis

1 reference

12 December 2020

JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Mycophenolate mofetil for myasthenia gravis: a clear and present controversy

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus

1 reference

12 December 2020

Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus

1 reference

12 December 2020

Patient fatalities potentially associated with efalizumab use.

1 reference

12 December 2020

Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients

1 reference

12 December 2020

Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation

1 reference

12 December 2020

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.

1 reference

12 December 2020

A novel targeted T-cell modulator, efalizumab, for plaque psoriasis

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?

1 reference

12 December 2020

Detection of JC virus DNA fragments but not proteins in normal brain tissue.

1 reference

12 December 2020

Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy.

1 reference

12 December 2020

JC virus detection in bodily fluids: clues to transmission

1 reference

12 December 2020

Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy

1 reference

12 December 2020

AIDS- and non-AIDS-related PML association with distinct p53 polymorphism

1 reference

12 December 2020

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study

1 reference

12 December 2020

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

1 reference

12 December 2020

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

1 reference

12 December 2020

B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny.

1 reference

12 December 2020

Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation.

1 reference

12 December 2020

Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.

1 reference

12 December 2020

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists.

1 reference

12 December 2020

Excretion and transmission of JCV in human populations

1 reference

12 December 2020

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

1 reference

12 December 2020

Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993.

1 reference

12 December 2020

A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

1 reference

12 December 2020

Interaction of the human polyomavirus, JCV, with human B-lymphocytes

1 reference

12 December 2020

Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-infected patients with or without progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study

1 reference

12 December 2020

Tolerance induction in the adult using monoclonal antibodies to CD4, CD8, and CD11a (LFA-1)

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

1 reference

12 December 2020

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

1 reference

12 December 2020

Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.

1 reference

12 December 2020

Cellular and humoral immune response in progressive multifocal leukoencephalopathy

1 reference

12 December 2020

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

1 reference

12 December 2020

Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)

1 reference

12 December 2020

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

1 reference

12 December 2020

Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals

1 reference

12 December 2020

Mycophenolate mofetil: An update

1 reference

12 December 2020

The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy

1 reference

12 December 2020

The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line

1 reference

12 December 2020

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

1 reference

12 December 2020

Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin.

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients.

1 reference

12 December 2020

Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Ins and outs of LFA-1

1 reference

12 December 2020

JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency.

1 reference

12 December 2020

Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody

1 reference

12 December 2020

High incidence of JC viruria in JC-seropositive older individuals

1 reference

12 December 2020

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

12 December 2020

Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.

1 reference

12 December 2020

Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world

1 reference

12 December 2020

The B cell--old player, new position on the team

1 reference

12 December 2020

JC virus viremia in interferon-beta -treated and untreated Italian multiple sclerosis patients and healthy controls

1 reference

12 December 2020

Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab.

1 reference

12 December 2020

Progressive Multifocal Leukoencephalopathy in a Male Homosexual with T-Cell Immune Deficiency

1 reference

12 December 2020

Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data

1 reference

12 December 2020

Immune response in progressive multifocal leukoencephalopathy: an overview

1 reference

12 December 2020

Thiazolidinedione-induced congestive heart failure

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in a patient with acquired immune deficiency syndrome.

1 reference

12 December 2020

Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV.

1 reference

12 December 2020

Mechanism of action of mycophenolate mofetil

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

1 reference

12 December 2020

The atypical antipsychotic agents ziprasidone [correction of zisprasidone], risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy

1 reference

12 December 2020

PARTICLES RESEMBLING PAPOVA VIRUSES IN HUMAN CEREBRAL DEMYELINATING DISEASE.

1 reference

12 December 2020

Progressive multifocal leukoencephalitis (PML) in three patients treated with standard-dose fludarabine (FAMP)

1 reference

12 December 2020

Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies

1 reference

12 December 2020

Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy

1 reference

12 December 2020

Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis

1 reference

12 December 2020

Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

1 reference

12 December 2020

Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.

1 reference

12 December 2020

Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases.

1 reference

12 December 2020

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

1 reference

12 December 2020

Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS.

1 reference

12 December 2020

Prevalence of JC virus viraemia in HIV-infected patients with or without neurological disorders: a prospective study.

1 reference

12 December 2020

The changing pattern of HIV neuropathology in the HAART era.

1 reference

12 December 2020

Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains

1 reference

12 December 2020

The neurologic complications of B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

1 reference

12 December 2020

Asymptomatic reactivation of JC virus in patients treated with natalizumab

1 reference

12 December 2020

A review of the current use of rituximab in autoimmune diseases

1 reference

12 December 2020

Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis

1 reference

12 December 2020

The human polyomavirus, JCV, uses serotonin receptors to infect cells

1 reference

12 December 2020

Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy

1 reference

12 December 2020

10.2165/11537510-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

1044609260

0 references

1 reference